A new study has shown that walking speed in older people is predictive of cardiovascular mortality, with those in the slowest tertile three times more likely to suffer CV death over five years than those who walked faster. 

Compugen Ltd. announced the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to Type 2 diabetes, the most common form of diabetes.

Olmesartan reduced the risk of microalbuminuria by 23% in normoalbuminuric patients with Type 2 diabetes and at least one additional cardiovascular disease risk factor, results from a large European trial showed.

An already routine blood test may identify juvenile-onset diabetic patients at heightened risk for proliferative retinopathy, researchers said.

Low birth weight increases the risk of developing Type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it seems that genetic background may also play a major role. 

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem.

New research suggests men over 50 are nearly twice as likely to have undiagnosed Type 2 diabetes than their female counterparts.

New data confirms the rate of chronic kidney disease is increasing along with the rising rates of diabetes. Up to 40% of people with diabetes will experience kidney problems in their lifetime.

The FDA has issued a public health advisory warning patients and physicians that concomitant use of clopidogrel (Plavix) and …

Danish drugmaker Novo, the world’s biggest insulin maker, stated that it is making progress in developing a tablet form of the drug — a holy grail of diabetes therapy.